Delivery Order SPE2DB20D3103-SPE2DB26FL3V4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging) valued at $6,857.16. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,344.93 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count package) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency awarded a $2,212.01 delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count package) on September 2, 2025, with an ultimate completion date of September 3, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $7,668.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (90-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Kerendia 10 mg tablets in a 30-count quantity, with a contract ceiling value of $10,409.41. This award represents a firm fixed-price, non-set-aside delivery order to be performed at the vendor's Conshohocken, Pennsylvania location, with an ultimate completion date of October 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $1,210.89 delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count supply) on October 27, 2025, with an ultimate completion date of October 28, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child award, this delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,312.01 to AmerisourceBergen Drug Corp for supply of Kerendia 10 mg tablets (90-unit quantity) on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Kerendia 10 mg tablets (30-count units) with a contract ceiling value of $59,930.82. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $2,737.75 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Kerendia 10 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $6,857.16, was competitively awarded with no set-aside designation and is scheduled for completion by August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL3V4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count) on October 27, 2025, with a ceiling value of $1,466.44 and an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under AmerisourceBergen's existing pharmaceutical supply contract with DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling DLA medical supply chain requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/27/25 |